All SEC Filings :: Kintara Therapeutics, Inc. (KTRA)

Filing Type:

Year:

Date	Form	Description	Pages
08/21/20	3	Initial statement of beneficial ownership of securities Documents EX-24	2
08/21/20	3	Initial statement of beneficial ownership of securities Documents EX-24	2
08/18/20	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	2
08/17/20	8-K	Current report filing Documents EX-99.1	6
08/17/20	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Documents EX-99.1	6
07/28/20	425	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions	2
07/02/20	EFFECT	Notice of Effectiveness	1
07/02/20	424B3	Prospectus filed pursuant to Rule 424(b)(3)	498
07/02/20	3	Initial statement of beneficial ownership of securities Documents EX-24	2
07/02/20	S-4/A	Registration of securities issued in business combination transactions Documents EX-5.1 EX-8.1 EX-10.43 EX-23.3 EX-23.4 EX-99.1 EX-99.2 EX-99.3 EX-99.4	538